PD-1 receptor deficiency enhances CD30+ Treg cell function in melanoma

Nat Immunol. 2025 Jul;26(7):1074-1086. doi: 10.1038/s41590-025-02172-0. Epub 2025 Jun 2.

Abstract

Regulatory T (Treg) cells are vital for immune suppression. The role of the coreceptor programmed cell death 1 receptor (PD-1) in Treg cell function is controversial. Here, we demonstrate that PD-1 deficiency enhances the function of Treg cells through expression of a compensatory network of coinhibitory receptors. CD30 has a central role within this network, driving the Treg cell suppressive function within the tumor microenvironment. Mechanistically, PD-1 deficiency enhances STAT5 signaling in Treg cells, which induces CD30 expression. These data indicate a role for PD-1 as a checkpoint that negatively controls CD30 expression in Treg cells to limit their suppressive function. Understanding the functional changes that PD-1 has on Treg cells might enable combination therapies with better treatment outcomes in cancer.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Humans
  • Ki-1 Antigen* / genetics
  • Ki-1 Antigen* / immunology
  • Ki-1 Antigen* / metabolism
  • Melanoma* / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Programmed Cell Death 1 Receptor* / deficiency
  • Programmed Cell Death 1 Receptor* / genetics
  • Programmed Cell Death 1 Receptor* / immunology
  • Programmed Cell Death 1 Receptor* / metabolism
  • STAT5 Transcription Factor / metabolism
  • Signal Transduction
  • T-Lymphocytes, Regulatory* / immunology
  • T-Lymphocytes, Regulatory* / metabolism
  • Tumor Microenvironment / immunology

Substances

  • Programmed Cell Death 1 Receptor
  • Ki-1 Antigen
  • STAT5 Transcription Factor
  • Pdcd1 protein, mouse